If you had invested $1,000 in Bristol-Myers Squibb Company (BMY)

10 years ago (Mon, Nov 7, 2016), $1,000 in BMY grew to $1,686 by Fri, Nov 6, 2026 with dividends reinvested ($1,181 on price alone). The same $1,000 in SPY grew to $4,042. Along the way BMY fell as much as -47.7% from a high. Past results do not tell you what happens next.

InvestedBMY, dividends reinvestedPer yearWorst fallSPYSPY per year
1 year ago$1,392+39.2%-15.9%$1,109+10.9%
3 years ago$1,356+10.7%-29.9%$1,750+20.5%
5 years ago$1,286+5.2%-47.7%$1,677+10.9%
10 years ago$1,686+5.4%-47.7%$4,042+15.0%

Today: model fair value $97.88 against a $62.14 price (gap +57.5%).

Split-adjusted closes; 40 cash dividends reinvested on their ex-dividend dates, before taxes and costs. SPY on its total-return price. Data as of Fri, Nov 6, 2026.

Full BMY valuation · Other companies